 3. The patient has received radiation therapy to the measurable tumor within 6 months. Patients are allowed to have local irradiation for the management of tumor-related symptoms bones, brain. However, if a patient has active new disease growing in the previously irradiated site, the patient will be eligible to participate in the study. 